Herbert G Chissell Iii, MD | |
900 Seton Dr, Cumberland, MD 21502-1854 | |
(301) 723-5030 | |
(301) 723-1480 |
Full Name | Herbert G Chissell Iii |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 900 Seton Dr, Cumberland, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982659728 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084F0202X | Psychiatry & Neurology - Forensic Psychiatry | D0018519 (Maryland) | Primary |
2084P0800X | Psychiatry & Neurology - Psychiatry | D0018519 (Maryland) | Primary |
Entity Name | State Of Maryland - University Of Maryland College Park |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841281680 PECOS PAC ID: 7416859327 Enrollment ID: O20040122000210 |
News Archive
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
Bacteria are among the simplest organisms in nature, but many of them can still talk to each other, using a chemical "language" that is critical to the process of infection. Sending and receiving chemical signals allows bacteria to mind their own business when they are scarce and vulnerable, and then mount an attack after they become numerous enough to overwhelm the host's immune system.
A major international trial has shown a commonly used chemotherapy drug is as effective at helping prevent pancreatic cancer returning after surgery as the more expensive standard chemotherapy treatment, reveals a study published in the Journal of the American Medical Association today (Wednesday).
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that the first procedure in Spain utilizing its cPAX Aneurysm Treatment System was performed in Madrid. cPAX received CE Mark earlier this year.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Herbert G Chissell Iii, MD 330 Suffolk Rd, Baltimore, MD 21218-2521 Ph: (410) 467-7448 | Herbert G Chissell Iii, MD 900 Seton Dr, Cumberland, MD 21502-1854 Ph: (301) 723-5030 |
News Archive
RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
Bacteria are among the simplest organisms in nature, but many of them can still talk to each other, using a chemical "language" that is critical to the process of infection. Sending and receiving chemical signals allows bacteria to mind their own business when they are scarce and vulnerable, and then mount an attack after they become numerous enough to overwhelm the host's immune system.
A major international trial has shown a commonly used chemotherapy drug is as effective at helping prevent pancreatic cancer returning after surgery as the more expensive standard chemotherapy treatment, reveals a study published in the Journal of the American Medical Association today (Wednesday).
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that the first procedure in Spain utilizing its cPAX Aneurysm Treatment System was performed in Madrid. cPAX received CE Mark earlier this year.
› Verified 9 days ago
Saiqa Choudhry, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 625 Kent Ave Ste 302, Cumberland, MD 21502 Phone: 301-777-1930 Fax: 301-777-8470 | |
Dr. Nirmalam Nagulendran, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 301-777-5627 Fax: 301-777-5630 | |
Dr. Jeremy Alan Herschler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd Se, Cumberland, MD 21501 Phone: 301-759-5280 | |
Edward Michael Ehlers, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 900 Seton Dr, Cumberland, MD 21502 Phone: 301-723-5030 Fax: 301-723-6485 | |
Samuel Navaratnam Nava, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 81 Baltimore St, Suite 216, Cumberland, MD 21502 Phone: 301-777-9330 | |
Stephen Schellhase, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 915 Bishop Walsh Rd, Cumberland, MD 21502 Phone: 301-724-7277 Fax: 301-724-7022 | |
Steven F Kendell, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd Ste 380, Cumberland, MD 21502 Phone: 240-964-8585 Fax: 240-964-8586 |